23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the SEC. The company filed for for Chapter 11 bankruptcy protection in March. Regeneron Pharmaceuticals ...
SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced its intention to file ...
23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange Commission, according to a release. Limited time: Save 25% on NBC News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results